Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Substance Misuse To Psychiatric Disorders for Etomidate -Repetitive Transcranial Magnetic Stimulation for People With Etomidate Addiction: a 6-month, Double-blind, Randomized, Sham-controlled Trial

NCT07736742 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT07736742
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07736742 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Substance Misuse To Psychiatric Disorders for Etomidate -Repetitive Transcranial Magnetic Stimulation for People With Etomidate Addiction: a 6-month, Double-blind, Randomized, Sham-controlled Trial
Lead sponsor
The University of Hong Kong
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
March 31, 2029
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

etomidate use disorder, repetitive transcranial magnetic stimulation (rtms)